Bryce Istvan

Long/short equity, growth, biotech
Bryce Istvan
Long/short equity, growth, biotech
Contributor since: 2011
10/16/12
Bryce Istvan
Npsp. Positive 12-0 ad comm. Unknown if stock will reopen today.
10/16/12
NPSP Stock reopened in the after hours. Down slightly.
6/8/12
Bryce Istvan
NPSP down on failed AMGN "Evolve" trial. Means no expanded indication for Sensipar and no extra royalties http://bit.ly/MiIJsj
3/20/12
Bryce Istvan
CBIO tanking after decision not to file for approval of -5214. Why was this a surprise? http://seekingalpha.com/a/6r18
2/1/12
Bryce Istvan
MACK postponing its IPO. Likely investors thought valuation was too high as Erb technology not fully validated. We'll see if they try again
1/24/12
Bryce Istvan
AAPL selling off late. Essentially where it was at before last quarter's disaster. Is this "sell the news" pressure or are investors antsy?
big players chickening out at the last minute.
1/17/12
Bryce Istvan
ORIG +9% today. Anyone see news or is this the company in working its buyback program?